Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells

Journal of Urology

Volumn 149, Issue 5, 1993, Pages 1209-1213

  Hoosein, N M ^a   Logothetis, C J ^a   Chung, L W K ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

adenosine cyclic monophosphate; bombesin; neoplasm metastasis; prostatic neoplasms; vasoactive intestinal peptide

Indexed keywords

ADENYLATE CYCLASE; BOMBESIN; PEPTIDE HORMONE; SOMATOSTATIN; VAPREOTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ARTICLE; BASEMENT MEMBRANE; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CELL INVASION; DOSE RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA;

EID: 0027189659     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(17)36349-8     Document Type: Article

References (26)

1. R.J. Cohen G. Glezerson Z. Haffejee D. Afrika Prostatic carcinoma: histological and immunohistological factors affecting prognosis Brit. J. Urol. 66 1990 405
2. D. Kadmon T.C. Thompson G.R. Lynch P.T. Scardino Elevated plasma chromogranin concentrations in prostatic carcinoma J. Urol. 146 1991 358
3. V. Delmas M.-C. Dauge-Geffory L. Boccon-Gibod The neuroendocrine cancer of the prostate. Incidence and prognosis. 400 patients J. Urol. 147 1992 332A
4. E.A. Turbat-Herrera G.A. Herrera I. Gore R.L. Lott W.E. Grizzle J.M. Bonnin Neuroendocrine differentiation in prostatic carcinomas: a retrospective autopsy study Arch. Pathol. Lab. Med. 112 1988 1100
5. P.A. Di Sant’Agnese K.L. de Mesy Jensen Neuroendocrine differentiation in prostatic carcinoma Hum. Pathol. 18 1987 849
6. P.A. Abrahamsson S. Falkner K. Falt L. Grimelius The course of neuroendocrine differentiation in prostatic carcinomas Pathol. Res. Pract. 185 1989 373
7. B. Tetu J.Y. Ro A.G. Ayala D.E. Johnson C.J. Logothetis N.G. Ordonez Small cell carcinoma of the prostate. Part I Cancer 59 1987 1803
8. M.E. Jelbart P.J. Russell P. Rusell D. Raghavan The biology and management of small cell undifferentiated carcinoma of the prostate C.J. Williams J.G. Krikorian M.R. Green D. Raghavan Textbook of Uncommon Cancer 1988 John Wiley and Sons, Ltd. New York 249
9. M. Fekete T.W. Redding A.M. Comaru-Schally J.E. Pontes R.W. Connelly G. Skralovic A.V. Schally Receptors for leutinizing hormone releasing hormone, somatostatin, prolactin and epidermal growth factor in rat and human prostate cancers and benign prostate hyperplasia Prostate 14 1989 191
10. M.E. Jelbart P.J. Russell M. Fullerton P. Russell J. Funder D. Raghavan Ectopic hormone production by a prostatic small cell carcinoma xenograft line Mol. Cell. Endocr. 55 1988 167
11. I.L. Avis T.O.G. Kovacs P.G. Kasprzyk A.M. Treston R. Bartholomew J.H. Walsh F. Cuttitta J.L. Mulshine Preclinical evaluation of an anti-autocrine growth factor monoclonal antibody for treatment of patients with small-cell lung cancer J. Natl. Can. Inst. 83 1991 1470
12. J. Shimoda D. Koh T. Kigure T. Harada S. Tsuchida K. Kudo Effect of bombesin and its antibody on human prostatic carcinoma cell lines (DU-145), PC-3) J. Urol 145 1991 400A
13. M. Bologna C. Festuccia P. Muzi L. Biordi M. Ciomei Bombesin stimulates growth of human prostatic cancer cells in vitro Cancer 63 1989 1714
14. J.R.A. Higgins J.A. Gosling Studies on the structure and intrinsic innervation of the normal human prostate Prostate 2 suppl. 1989 5
15. W. Lange J. Unger Peptidergic innervation within the prostate gland and seminal vesicle Urol. Res. 18 1990 337
16. M.J. Carmena J.I. Sancho M.A. Fernandez-Gonzalez F. Escudero J.C. Prieto Somatostatin inhibits VIP- and isoproterenol-stimulated cyclic AMP accumulation in rat prostatic epithelial cells FEBS Letters 218 1987 73
17. A. Albini Y. Iwamoto H.K. Kleinman G.R. Martin S.A. Aaronson J.M. Kozlowski Rapid in vitro assay for quantitating the invasive potential of tumor cells Cancer Res. 47 1987 3239
18. N.M. Hoosein D.B. Boyd W.J. Hollas A.M. Mazar J. Henkin L.W.K. Chung Involvement of urokinase and its receptor in determining the invasiveness of human prostatic carcinoma cell lines Cancer Commun. 3 1991 255
19. N.M. Hoosein R.S. Gurd Identification of glucagon receptors in rat brain Proc. Natl. Acad. Sci. USA 81 1984 4368
20. J.C. Reubi S.W.J. Lamberts R. Maurer Somatostatin receptors in normal and tumoral tissue Hormone Res. 29 1988 65
21. M.M. Mareel F.M. Van Roy P. De Baetselier The invasive phenotypes Cancer Metastsis Rev. 9 1990 45
22. L.Y. Korman D.N. Carney M.L. Citron T. Moody Secretin/VIP-stimulated secretion of bombesin/GRP from human small cell lung cancer Cancer Res. 46 1986 1214
23. A.V. Schally T.W. Redding Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer Proc. Natl. Acad. Sci. USA 84 1987 7275
24. Y. Nagamine E. Reich Gene expression and cAMP Proc. Natl. Acad. Sci. USA 82 1985 4606
25. Y.J. Bang S.J. Kim D. Danielpour M.A. O’Reilly K.Y. Kim C.E. Myers J.B. Trepel Cyclic AMP induces transforming growth factor beta 2 gene expression and growth arrest in the human androgen-independent prostate carcinoma cell line PC-3 Proc. Natl. Acad. Sci. USA 89 1992 3556
26. D.L. Mooradian J.B. McCarthy K.V. Komanduri L.T. Furcht Effects of transforming growth factor-beta 1 on human pulmonary adenocarcinoma cell adhesion, motility and invasion in vitro J. Natl. Cancer Inst. 84 1992 523